Technical Analysis for CLSN - Celsion Corporation

Grade Last Price % Change Price Change
grade F 2.05 -4.21% -0.09
CLSN closed down 4.21 percent on Monday, May 20, 2019, on 80 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CLSN trend table...

Date Alert Name Type % Chg
Stochastic Reached Oversold Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish -4.21%
50 DMA Resistance Bearish -4.21%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.21%
200 DMA Resistance Bearish -4.65%
Fell Below 20 DMA Bearish -4.65%

Older signals for CLSN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. The company develops ThermoDox, a liposomal encapsulation of doxorubicin, which is under Phase III clinical trial for primary liver cancer; under phase II clinical trial for colorectal liver metastasis; and under phase II clinical trial for treatment of recurrent chest wall breast cancer. It has a development, product supply, and commercialization agreement with Yakult Honsha Co. for ThermoDox; and a joint research agreement with Royal Philips Electronics to evaluate the combination of Philips' high intensity focused ultrasound with its ThermoDox to determine the potential of this combination to treat various cancers. The company was founded in 1982 and is based in Lawrenceville, New Jersey.
Medicine Cancer Clinical Medicine Cancers Chemotherapy Ultrasound Antineoplastic Drugs Drug Development Hepatocellular Carcinoma Hepatology Anthracyclines Doxorubicin High Intensity Focused Ultrasound
Is CLSN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.48
52 Week Low 1.35
Average Volume 186,361
200-Day Moving Average 2.2647
50-Day Moving Average 2.215
20-Day Moving Average 2.2013
10-Day Moving Average 2.161
Average True Range 0.1317
ADX 10.36
+DI 16.1509
-DI 15.0543
Chandelier Exit (Long, 3 ATRs ) 2.0249
Chandelier Exit (Short, 3 ATRs ) 2.4251
Upper Bollinger Band 2.3537
Lower Bollinger Band 2.0489
Percent B (%b) 0.0
BandWidth 13.846364
MACD Line -0.0283
MACD Signal Line -0.0155
MACD Histogram -0.0128
Fundamentals Value
Market Cap 17.12 Million
Num Shares 8.35 Million
EPS -5.58
Price-to-Earnings (P/E) Ratio -0.37
Price-to-Sales 47.77
Price-to-Book 2.54
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.23
Resistance 3 (R3) 2.24 2.20 2.20
Resistance 2 (R2) 2.20 2.15 2.19 2.19
Resistance 1 (R1) 2.12 2.12 2.10 2.11 2.18
Pivot Point 2.08 2.08 2.06 2.07 2.08
Support 1 (S1) 2.00 2.03 1.98 1.99 1.92
Support 2 (S2) 1.96 2.00 1.95 1.91
Support 3 (S3) 1.88 1.96 1.90
Support 4 (S4) 1.87